143 related articles for article (PubMed ID: 27931059)
1. [Not Available].
Reck M
Pneumologie; 2016 Dec; 70(12):835. PubMed ID: 27931059
[No Abstract] [Full Text] [Related]
2. [The Viennese Clinical Weekly and the Austrian Society for Pneumology].
Burghuber OC
Wien Klin Wochenschr; 2008; 120(15-16):452-3. PubMed ID: 18820844
[No Abstract] [Full Text] [Related]
3. [Not Available].
Klee H
Pneumologie; 2016 Dec; 70(12):835. PubMed ID: 27931060
[No Abstract] [Full Text] [Related]
4. 39th Annual Meeting of the American Society of Clinical Oncology: Chicago, Illinois, May 30 to June 3, 2003.
Lee D; DeGrendele H
Clin Lung Cancer; 2003 Jul; 5(1):13-7. PubMed ID: 14596697
[No Abstract] [Full Text] [Related]
5. [Evolution and revolution in systemic treatment of lung cancer. The new role of immunotherapy].
Duruisseaux M; Berghmans T
Rev Mal Respir; 2018 Feb; 35(2):101-102. PubMed ID: 29548518
[No Abstract] [Full Text] [Related]
6. Perspectives for onkologie.
Schmoll HJ; Hallek M
Onkologie; 2011; 34(12):659. PubMed ID: 22156443
[No Abstract] [Full Text] [Related]
7. Advances highlighted at US cancer meeting.
McCarthy M
Lancet; 2002 May; 359(9320):1835. PubMed ID: 12044383
[No Abstract] [Full Text] [Related]
8. Editorial--"transition, change, growth, and sustainability".
Ashbury F
Support Care Cancer; 2009 Jan; 17(1):1-2. PubMed ID: 19037668
[No Abstract] [Full Text] [Related]
9. [Bevacizumab in thoracic oncology: results and practical aspects].
Dansin É; Cousin S; Lauridant G; Mennecier B
Rev Pneumol Clin; 2013 Jun; 69(3):159-69. PubMed ID: 23597632
[TBL] [Abstract][Full Text] [Related]
10. American Society of Clinical Oncology Annual Meeting 2013.
Yaqub F
Lancet Respir Med; 2013 Jul; 1(5):360-1. PubMed ID: 24429195
[No Abstract] [Full Text] [Related]
11. [The place of targeted therapies in the management of non-small cell bronchial carcinoma. Methodology of the development of targeted therapies in pulmonary oncology].
Pérol M
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S148-16S157. PubMed ID: 17268352
[TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
[No Abstract] [Full Text] [Related]
13. [Cancer of the lung. New perspectives in medical treatment].
Gallo Curcio C
Arch Monaldi Mal Torace; 1989; 44(4-6):781-90. PubMed ID: 2577795
[No Abstract] [Full Text] [Related]
14. [Recent development in the treatment of lung cancer: from the point of view of the medical oncologist].
Joss R
Schweiz Med Wochenschr; 2000 May; 130(19):684-90. PubMed ID: 10846762
[TBL] [Abstract][Full Text] [Related]
15. Current treatment of non-small cell lung cancer.
Tonato M
Suppl Tumori; 2002; 1(4):S7-8. PubMed ID: 12415804
[No Abstract] [Full Text] [Related]
16. Focus on maintenance therapy in non-small-cell lung cancer.
Tartarone A
Future Oncol; 2015; 11(2):189-92. PubMed ID: 25591835
[No Abstract] [Full Text] [Related]
17. The need for adequate coverage of oncology topics in internal medicine journals.
Tefferi A
Mayo Clin Proc; 2008 Sep; 83(9):980-2. PubMed ID: 18775196
[No Abstract] [Full Text] [Related]
18. Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting.
Langer CJ
Clin Lung Cancer; 2008 Sep; 9(5):249-51. PubMed ID: 18824445
[No Abstract] [Full Text] [Related]
19. [Non-small-cell lung carcinoma (NSCLC): from ASCO 2004 to clinical practice].
Pérol M
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S46-4S52. PubMed ID: 15687995
[No Abstract] [Full Text] [Related]
20. Molecular targeted agents and biologic therapies for non-small cell lung cancer.
Somaiah N; Simon GR
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S434-54. PubMed ID: 21102235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
